ADC Market Growth Surges on High MMAE Usage
According to a new research report by RNCOS entitled, "Global Antibody Drug Conjugate Market Outlook 2018", an ADC is designed by site-specific conjugation of cytotoxic agent (drugs) to a monoclonal antibody. Cytotoxic agents are drugs which are used in the treatment of cancer. By combining the functionalities of a drug and antibody, pharmacokinetic parameters and therapeutic action of antibody drug conjugate are improved. Industry leaders are using several kinds of potent agents such as Monomethyl auristatin E, maytansine derivatives and...
View full press release